Short answer
Kodiak Sciences Inc. (KOD) filed its Q3 2025 10-Q quarterly report on Nov 13, 2025 for the quarter ended Sep 30, 2025.
Q3 2025 key financials · XBRL
- Net income
- −$61M
- −39.8% YoY · −13.2% QoQ
- EPS (diluted)
- −$1.16
- −39.8% YoY · −12.6% QoQ
Source: XBRL data from the Kodiak Sciences Inc. (KOD) Q3 2025 10-Q on SEC EDGAR. USD.
Kodiak Sciences Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk: macroeconomic uncertainties including inflation, tariffs, rising interest rates, and bank failures impacting liquidity and operations
- Updated risk: operational spend increased to $105.9 million for nine months ended Sept 30, 2025, cash used in operating activities $96.6 million vs $87.2 million prior year
- Compliance risk: no material changes to contractual obligations since 12/31/2024, other than Note 5 financial statement disclosures
- Market risk: ongoing geopolitical conflicts and supply chain disruptions may materially impact product development timelines
- Financial risk: cash decreased by $96.0 million in first nine months 2025, requiring continued capital raises for development and commercialization efforts
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Kodiak Sciences Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.